Vaccine Industry Procurement Intelligence Report with COVID-19 Impact Analysis 2020-2027

0
0

vaccine is a suspension of weakened, killed, or fragmented microorganisms or toxins or of antibodies or lymphocytes that is administered to stimulate the body’s immune response against the specific infectious agent or disease. Intramuscular is the most common mode of administration for vaccines. Majorly vaccines can be categorized into the following types based on their characteristics:

  • Live-attenuated vaccines
  • Inactivated vaccines
  • Subunit, recombinant, conjugate, and polysaccharide vaccines
  • Toxoid vaccines
  • mRNA vaccines
  • Viral vector vaccines

Read report summary or request a free sample copy of the report “Vaccine Industry Procurement Intelligence, Supplier Intelligence, Supplier Ranking, Pricing & Cost Structure Intelligence, Best Practices, Engagement Model, Low & Best Cost Country, Day One Analysis Report, 2020 – 2027

Demand Outlook

The global vaccine market was valued at USD 42 billion in 2020 and it is expected to grow at a CAGR of 7-8% from 2020 to 2027 due to the high prevalence of infectious diseases, increasing company initiatives to enhance vaccine R&D, growing government investments for vaccine development, and the rising focus on immunization. According to WHO immunization awareness and government initiatives have helped prevent 2-3 million deaths annually before Covid-19. The recombinant/conjugate vaccine segment is the largest market share of ~55% followed by inactivated and live attenuated vaccines. North America generated more than 35% of revenue of the global vaccine market owing to strong awareness, secure government policies regarding health welfare.

Cost Drivers

Vaccine manufacturing costs can be divided into two segments. Fixed costs and variable costs. Fixed costs include product development, facilities, and equipment costs. Variable costs include consumables, direct labor, licensing/regularization, commercialization, and overhead costs. Vaccine production costs have a significant fixed cost component, reaching up to 90% of total costs. Production costs per unit can be reduced significantly through gains in productivity and economies of scale. Because of the high fixed cost element, the cost of production per dose decreases with increasing batch size. For bulk production, equipment cost is the major cost component with more than 40% share in the overall cost of production. Whereas for lab-scale production the product development and raw material costs plays important role in determining the overall cost of production.

Browse our other Reports:

Key Players:

  • GlaxoSmithKline plc
  • Pfizer
  • Sanofi Pasteur
  • Merck & Co.
  • CSL Limited
  • Emergent BioSolutions, Inc.
  • Johnson & Johnson
  • AstraZeneca
  • Serum Institute of India Pvt. Ltd.
  • Bavarian Nordic
  • Mitsubishi Tanabe Pharma Corporation
  • Daiichi Sankyo Company
  • PanaceaBiotec
  • Bharat Biotech
  • Sinovac Biotech Ltd

The global vaccine industry features a moderately consolidated landscape with the leading players contributing around 55% of the market share. Industry leaders are strengthening their presence through multiple mergers and acquisitions.

Check out the featured Add-on Services offered with Vaccine Market Procurement Intelligence Report.

About us:

A smart and effective supply chain is essential for growth in any organization. Pipeline division at Grand View Research provides detailed insights on every aspect of the supply chain which helps in efficient procurement decisions.

Our services include (not limited to):

Market Intelligence involving – market size and forecast, growth factors, and driving trends

Price and Cost Intelligence – pricing models adopted for the category, the total cost of ownership

Supplier Intelligence – rich insight on supplier landscape, and identifies suppliers who are dominating, emerging, lounging, and specializing

Sourcing / Procurement Intelligence – best practices followed in the industry, identifying standard KPIs and SLAs, peer analysis, negotiation strategies to be utilized with the suppliers, and best-suited countries for sourcing to minimize supply chain disruption

 

Our market/procurement Intelligence reports include in-depth and actionable insights that help clients in understanding the different aspects of the supply chain and take more effective decisions.

Find More information @ https://www.grandviewresearch.com/pipeline 

Contact Information:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Follow Us: LinkedIn | Twitter

Showing 0 results
Your Answer

Please first to submit.

Get involved

Register

As a member of this site you will be able to receive aggregates news relating only to those categories that are most relevant to you, submit job listings for FREE, post questions in the Q&A, and more.

Register Now

Feature your company

The Feature Your Company listing is your custom-made (by us) profile page that allows you to add any of the following content: text, videos, links, images. The page will also be listed on the Featured Company landing page. Over 560 unique aggregates users visit the site per day! Complete the enquiry form now to contact us.

Contact us

Jobs

Are you looking for an aggregate related job? Click here to see our jobs listing supplied by industry experts United Employment.

See Jobs

Advertise

Reach thousands of budget holders and decision makers by promoting your company on the longest established aggregate website in the US & Canada. Or advertise in our emails which are sent to opted-in subscribers according to their chosen categories. All advertising will display correctly on tablets and mobiles as this site is responsive.